Zydus US011 is a clinical research site located in Seattle, Washington, United States 98122.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Zydus US011 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Amyotrophic Lateral Sclerosis (ALS).
Sponsors: Zydus Therapeutics Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Zydus US011 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Zydus US011 has 1 clinical trials on record, with 1 currently active. Their work covers Amyotrophic Lateral Sclerosis (ALS).
Zydus US011 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.